Ariad’s $5.2 Billion Sale To Takeda Nets $260 Million Windfall For Hedge Fund

From Hedge Fund News From HedgeCo.Net
January 10, 2017 - 8:38am

(Forbes) Takeda’s $5.2 billion takeover of Ariad Pharmaceuticals is turning into a major payday for a weighty but unheralded investor in the drug sector. Sarissa Capital, run by Carl Icahn protégé Alex Denner, stands to make $260 million on Monday’s […]



Continue reading this article »